110 related articles for article (PubMed ID: 3437612)
1. Serum levels of maprotiline and its adverse effects on depressed patients.
Kurata K; Kido H; Hasegawa M; Inoue M; Yamaguchi N
Jpn J Psychiatry Neurol; 1987 Jun; 41(2):247-54. PubMed ID: 3437612
[TBL] [Abstract][Full Text] [Related]
2. A comparison of maprotiline and its desmethylated metabolite serum concentrations in outpatients and inpatients.
Kurata K; Kido H; Hasegawa M; Inoue M; Yamaguchi N
Jpn J Psychiatry Neurol; 1987 Jun; 41(2):255-60. PubMed ID: 3437613
[TBL] [Abstract][Full Text] [Related]
3. Relationship between blood concentrations and clinical effects of a new antidepressant "maprotiline".
Watanabe S; Yokoyama S; Kubo S; Iwai H; Kuyama C
Folia Psychiatr Neurol Jpn; 1980; 34(2):147-56. PubMed ID: 7007180
[TBL] [Abstract][Full Text] [Related]
4. [Blood concentrations of maprotiline in depressive patients].
Rouillon F; Sioufi A; Serrurier D; Mizon JP; Plaquet R; Richard JB; Riche C; Bourin M; Kergueris MF; Besançon G
Encephale; 1988; 14(4):299-305. PubMed ID: 3058453
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of maprotiline and zimelidine and their relationship to clinical response in depressed patients.
Hrdina PD; Lapierre YD
Ther Drug Monit; 1986; 8(4):400-6. PubMed ID: 2950616
[TBL] [Abstract][Full Text] [Related]
6. Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
Schmauss M; Laakmann G; Dieterle D; Blaschke D
Pharmacopsychiatry; 1985 Jul; 18(4):282-5. PubMed ID: 3895255
[TBL] [Abstract][Full Text] [Related]
7. Complex visual disturbances during maprotiline treatment.
Yoshino T; Nisijima K; Shioda K; Kato S
Psychiatry Clin Neurosci; 2012 Oct; 66(6):533-4. PubMed ID: 23066771
[No Abstract] [Full Text] [Related]
8. Cross-over trial comparing the antidepressant effects of amineptine and maprotiline.
Bornstein S
Curr Med Res Opin; 1979; 6(2):107-10. PubMed ID: 380910
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis caused by antidepressive therapy with maprotiline and opipramol.
Braun JS; Geiger R; Wehner H; Schäffer S; Berger M
Pharmacopsychiatry; 1998 Jul; 31(4):152-5. PubMed ID: 9754852
[TBL] [Abstract][Full Text] [Related]
10. Incidence of seizures with tricyclic and tetracyclic antidepressants.
Jabbari B; Bryan GE; Marsh EE; Gunderson CH
Arch Neurol; 1985 May; 42(5):480-1. PubMed ID: 3994566
[TBL] [Abstract][Full Text] [Related]
11. Seizures associated with high maprotiline serum concentrations.
Molnar G
Can J Psychiatry; 1983 Nov; 28(7):555-6. PubMed ID: 6418369
[TBL] [Abstract][Full Text] [Related]
12. GLC-mass spectrometric determination of maprotiline and its major metabolite using stable isotope-labeled analog as internal standard.
Jindal SP; Lutz T; Vestergaard P
J Pharm Sci; 1980 Jun; 69(6):684-7. PubMed ID: 7205583
[TBL] [Abstract][Full Text] [Related]
13. Non-response to maprotiline caused by ultra-rapid metabolism that is different from CYP2D6?
Vormfelde SV; Bitsch A; Meineke I; Gundert-Remy UM; Gleiter CH
Eur J Clin Pharmacol; 1997; 52(5):387-90. PubMed ID: 9272409
[TBL] [Abstract][Full Text] [Related]
14. Response to maprotiline treatment in depressive patients relationship to urinary MHPG excretion and plasma drug level.
Gaertner HJ; Golfinopoulos G; Breyer-Pfaff U
Pharmacopsychiatria; 1982 Sep; 15(5):170-4. PubMed ID: 7178231
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, side-effects, plasma and blood levels of maprotiline (Ludiomil).
Miller PI; Beaumont G; Seldrup J; John V; Luscombe DK; Jones R
J Int Med Res; 1977; 5 Suppl 4():101-11. PubMed ID: 590605
[TBL] [Abstract][Full Text] [Related]
16. Depression in the elderly: pharmacologic considerations in treatment.
Veith RC
J Am Geriatr Soc; 1982 Sep; 30(9):581-6. PubMed ID: 6125536
[TBL] [Abstract][Full Text] [Related]
17. Chemistry, pharmacology, pharmacokinetics, adverse effects, and efficacy of the antidepressant maprotiline hydrochloride.
Wells BG; Gelenberg AJ
Pharmacotherapy; 1981; 1(2):121-39. PubMed ID: 6765485
[TBL] [Abstract][Full Text] [Related]
18. Recognizing and treating depressed patients with maprotiline.
Lerfald SC
Md State Med J; 1982 Nov; 31(11):44-7. PubMed ID: 7176695
[No Abstract] [Full Text] [Related]
19. Quantitative high-performance liquid chromatographic assay for the determination of maprotiline and oxaprotiline in human plasma.
Kuss HJ; Feistenauer E
J Chromatogr; 1981 Jan; 204():349-53. PubMed ID: 7217264
[TBL] [Abstract][Full Text] [Related]
20. Maprotiline in affective illness. Plasma concentration and clinical response.
Norman TR; Burrows GD; Maguire KP; McIntyre IM; Scoggins BA
J Affect Disord; 1983 May; 5(2):147-54. PubMed ID: 6222094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
